Acadia Healthcare Company (ACHC) Posts Quarterly Earnings, Beats Estimates By $0.01 EPS
Acadia Healthcare Company (NASDAQ:ACHC) released its earnings data on Tuesday. The company reported $0.32 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.31 by $0.01, AnalystRatingsNetwork reports. The company had revenue of $213.80 million for the quarter, compared to the consensus estimate of $207.73 million. During the same quarter in the prior year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 20.5% on a year-over-year basis. Acadia Healthcare Company updated its FY14 guidance to $1.44-1.46 EPS.
Acadia Healthcare Company (NASDAQ:ACHC) traded down 1.62% during mid-day trading on Tuesday, hitting $49.78. 1,035,078 shares of the company’s stock traded hands. Acadia Healthcare Company has a 52-week low of $34.08 and a 52-week high of $53.87. The stock has a 50-day moving average of $46.46 and a 200-day moving average of $46.52. The company has a market cap of $2.528 billion and a price-to-earnings ratio of 48.98.
A number of analysts have recently weighed in on ACHC shares. Analysts at Zacks upgraded shares of Acadia Healthcare Company from a “neutral” rating to an “outperform” rating in a research note on Tuesday, July 1st. They now have a $49.00 price target on the stock. Analysts at Raymond James reiterated an “outperform” rating on shares of Acadia Healthcare Company in a research note on Wednesday, June 4th. They now have a $55.00 price target on the stock, up previously from $49.00. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Acadia Healthcare Company presently has a consensus rating of “Buy” and an average target price of $52.00.
Acadia Healthcare Company, Inc is a provider of inpatient behavioral healthcare services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.